ASMTY (which stands for acetylserotonin methyltransferase),
TSPY (testis-specific protein),
IL3RAY (interleukin-3 receptor),
SRY (sex-determining region),
TDF (testis determining factor),
ZFY (zinc finger protein), PRKY (protein kinase, Y-linked),
CSF2RY (granulocyte-macrophage colony-stimulating factor receptor, alpha subunit on the Y chromosome),
ANT3Y (adenine nucleotide translocator-3 on the Y),
AZF2 (azoospermia factor 2),
BPY2 (basic protein on the Y chromosome),
AZF1 (azoospermia factor 1),
DAZ (deleted in azoospermia),
RBM1 (RNA binding motif protein, Y chromosome, family 1, member A1),
RBM2 (RNA binding motif protein 2) and
UTY (ubiquitously transcribed TPR gene on Y chromosome).
- In situ hybridization, fluorescent
An important molecular cytogenetic method for identifying chromosomes and parts of chromosomes, deciphering chromosome rearrangements, and locating genes on chromosomes. “Fluorescent” means emitting light that comes from a reaction within the emitter. “In situ” refers to the fact that this techniques is done with the chromosomes, cells or tissue in place (in situ) on a […]
- In situ hybridization
The use of a DNA or RNA probe to detect complementary genetic material in cells or tissue. In situ hybridization involves hybridizing a labeled nucleic acid to suitably prepared cells or tissues on microscope slides to allow visualization in situ (in the normal location).
- In situ
In the normal location. An in situ tumor is one that is confined to its site of origin and has not invaded neighboring tissue or gone elsewhere in the body. For example, squamous cell carcinoma in situ is an early stage of skin cancer.
- Inherited immunodeficiency disease
Primary immunodeficiency disease.
- Inherited metabolic diseases
the presence of uric acid in the urine of people with gout).